Vanta Bioscience Limited — Regulatory Filings 2026

May 26, 2026

VBS

Vanta Bioscience Limited

Regd. Office : 1-20-248, Umajay Complex, Rasoolpura, Secunderabad - 500 003, INDIA.

Tel : +91 40 6657 5454, 2790 3226

Fax : +91 40 2790 8708

Website: www.vantabio.com

Email : info@vantabio.com

CIN No.: L74999TG2016PLC109280

26.05.2026

Hyderabad

To

BSE Limited

Department of Corporate Services

25th Floor, Phiroze Jeejeehoy Towers,

Dalal Street, Mumbai – 400 001

Sub: Intimation of Board Meeting to be held on May 30, 2026

Ref: Scrip Code: 540729 | Scrip ID: VANTABIO

Dear Sir/Madam

Pursuant to provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, May 30, 2026 at 6:00 PM at the registered office of the Company, inter-alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31, 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon.

Further, in continuation to our previous intimation dated March 24, 2026, the Trading Window for all designated persons as under Insider Trading Policy of the Company shall remain closed from April 01, 2026 till June 1, 2026 (both days inclusive).

This is for your information and dissemination to the general public.

Thanking you

Yours faithfully

FOR VANTA BIOSCIENCE LIMITED

MULAKALA Digitally signed by MULAKALA DOPESH RAJA

DOPESH RAJA MULAKALA

MANAGING DIRECTOR

DIN: 01176660

The Right Dose of

Intelligent Toxicology

Research Center :

KZ-B, 11th Cross Street, SIPCOT Industrial Complex,

Gummidipoondi, Thiruvallur District, Tamilnadu - 601 201.

Tel: 044 6790 1600